NYC entrepreneurship conference features CEOs, NBA leader

The 2024 Eclectic Convergence conference in New York City, organized by Entrepreneurship at Cornell, is set for Nov. 15.

Around Cornell

Food hackathon to kick off year of weekend events

A year of hackathons kicks off Oct. 25-27 with the Food Hackathon in Stocking Hall, which focuses on finding solutions that address hunger, poor nutrition, food waste and other food-related challenges. 

Around Cornell

Dr. Randy Longman receives NIH Transformative Research Award

The award funds innovative but inherently risky research endeavors that have the potential to overturn existing scientific paradigms or create new ones.

Revising Medicare Part D prescription policy could save billions

Weill Cornell Medicine researchers have found that removing protected class regulation from Medicare prescription drug policies could greatly reduce the United States' prescription drug spending, potentially saving $47 billion between 2011 and 2019.

ILR School’s High Road New York City program receives support

Edwin “Ed” Baum ’81 and his wife, Holly Wallace, are supporting the New York City High Road initiative by funding stipends, subsidizing housing and providing robust program support.

Around Cornell

Researchers gain insights into KRAS mutations in pancreatic cancers

A mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma compared with other variants, according to a multicenter study conducted at Weill Cornell Medicine, NewYork-Presbyterian and other institutions.

Information scientist Nicola Dell named MacArthur Fellow

Nicola Dell, associate professor at the Jacobs Technion-Cornell Institute at Cornell Tech, and novelist Ling Ma, MFA ’16, have been awarded 2024 MacArthur Foundation fellowships — more commonly known as “genius grants.”

Alzheimer’s genetic risk factors spark inflammation in females

A new study emphasizes the importance of considering sex differences in Alzheimer’s research – a step that could ultimately lead to more precise and effective treatments.

New tool quantifies cancer’s ability to shape-shift

A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center.